Public annual accounts

Dr. Liesbeth Heremans financials

Name: Dr. Liesbeth Heremans financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Dr. Liesbeth Heremans, with comparable measures and links to available source documents.

Company overview

Registry number

0841949805

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for Dr. Liesbeth Heremans

2025 versus 2024

Operating line: €421,215
EBITDA: €417,370
Total assets: €1,738,881
Equity: €1,691,210

EBITDA margin +99.1% · Equity ratio +97.3%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€421,215	€417,370	€1,738,881	€1,691,210	-
202431 Dec 2024	€422,687	€420,512	€1,744,179	€1,669,121	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€421,215

€417,370

€1,738,881

€1,691,210

202431 Dec 2024

€422,687

€420,512

€1,744,179

€1,669,121